Evolent Health
EVH
178 hedge funds and large institutions have $1.71B invested in Evolent Health in 2018 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 58 increasing their positions, 48 reducing their positions, and 20 closing their positions.
1,802% more call options, than puts
Call options by funds: $5.42M | Put options by funds: $285K
145% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 20
52% more capital invested
Capital invested by funds: $1.13B → $1.71B (+$583M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
21% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 48
17% more funds holding
Funds holding: 152 → 178 (+26)
0.49% less ownership
Funds ownership: 106.09% → 105.6% (-0.49%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$27.7M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$21.2M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$16.6M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$16.4M |
| 5 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$14.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$29.6M |
| 2 |
TIM
Thornburg Investment Management
Santa Fe,
New Mexico
|
-$20.7M |
| 3 |
FG
Formula Growth
Montreal,
Quebec, Canada
|
-$19.1M |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$16.3M |
| 5 |
ECP
Elk Creek Partners
Denver,
Colorado
|
-$13M |
EVH Hedge Fund Activity: Q2 2018 in Review
178 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q2 2018, worth a combined $1.71B — up 52% from $1.13B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new EVH positions and 20 closed out — a net gain of 29 holders — while 58 added to existing stakes and 48 trimmed.
The largest buyer was Capital World Investors, opening a new position worth an estimated $27.7M. The largest seller was Capital Research Global Investors, cutting an estimated $29.6M.
- 178 institutional investors held Evolent Health (EVH) as of Q2 2018, up from 152 in Q1 2018.
- Funds reported $1.71B of Evolent Health stock for Q2 2018, up 52% quarter-over-quarter.
- 49 funds opened new Evolent Health positions in Q2 2018 and 20 closed out, a net change of +29 holders.
- The largest Evolent Health buyer in Q2 2018 was Capital World Investors, an estimated $27.7M added.
- The largest Evolent Health seller in Q2 2018 was Capital Research Global Investors, an estimated $29.6M sold.
Based on aggregated 13F filings for Q2 2018.